Clinical Characteristics of Children Needing Inpatient Treatment after Failed Outpatient Treatment for Fecal

Amrita Sinha1, Maroun Mhanna1, Reema Gulati2

  • 1Department of Pediatrics, MetroHealth Medical Center (MHMC) affiliated with Case Western Reserve University, Cleveland, OH, USA.

Insights

Children with chronic constipation needing hospitalization often present with earlier onset, black ethnicity, prematurity, developmental delay, and incontinence. Identifying these factors can help predict treatment challenges and prevent hospital admissions.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pediatrics
  • Child Health Outcomes

Background:

  • Chronic constipation and fecal impaction in children often require intensive outpatient laxative treatment.
  • A subset of children fail outpatient management, necessitating hospitalization for treatment.
  • Predicting which children will fail outpatient treatment is crucial for resource allocation and timely intervention.

Purpose of the Study:

  • To compare the characteristics of children with chronic constipation who failed outpatient treatment and required hospitalization versus those successfully treated as outpatients.
  • To identify specific attributes associated with a higher likelihood of hospitalization for pediatric constipation.

Main Methods:

  • Retrospective cohort study of pediatric patients (0-21 years) with chronic functional constipation and fecal impaction.
  • Analysis of medical records over a two-year period.
  • Comparison of demographic and clinical factors between hospitalized (inpatient) and successfully treated (outpatient) groups.

Main Results:

  • Out of 188 patients, 30.9% required hospitalization, while 69.2% were treated successfully as outpatients.
  • Inpatient group characteristics included earlier age at onset (3.6 years), black ethnicity (OR 4.31), prematurity (OR 2.39), developmental delay (OR 2.20), overflow incontinence (OR 2.26), picky eating (OR 2.02), more ROME III criteria (median 4), and more prior constipation encounters (13.7).
  • These factors were significantly associated with treatment failure and hospitalization.

Conclusions:

  • Specific patient characteristics are associated with a higher risk of hospitalization for chronic constipation.
  • Early identification of these risk factors can aid in anticipating treatment challenges.
  • This may lead to more proactive management strategies to prevent hospitalization.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K